None listed
Conditions
Interventions
Group 1 Type of group
Albendazole 400mg once daily
Group name:Group 2 Type of group
Metronidazole 20mg / Kg / day in three doses per day.
Sponsors
ASOCIACION CIVIL SELVA AMAZONICA, Universidad McGill, Canada,
Eligibility
Age
5 Years to 15 Years
Inclusion criteria
Inclusion criteria: • Primary school students belonging to the Educational Institutions of the Bethlehem District. • School boys and girls. • Positive diagnosis for Giardia duodenalis by coproparasitological analysis. • Informed consent signature of the parents or legal guardians of the students under study according to the Helsinki declaration. • Child´s consent confirming their willingness to participate in the study
Exclusion criteria
Exclusion criteria: • School children who do not voluntarily settle their participation in the study or whose parents or guardians do not sign the necessary informed consent for participation in the study. • Having received treatment against Giardia duodenalis or against intestinal helminths within 7 days prior to the start of the study. • Negative diagnosis for Giardia duodenalis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome name:Efficacy will be measured by the clinical examination performed for five consecutive days. Measure:Efficacy level Timepoints:5 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome name:Prevalence will be measured by clinical examination and laboratory tests performed for five consecutive days. Measure:Level of prevalence of Giardiasis in primary school students of the Bethlehem district. Timepoints:During treatment ; Outcome name:Record of adverse reactions occurred during the study. Measure:Emergence of adverse reactions Timepoints:During the study | — |
Countries
Peru
Contacts
Public ContactLilian Saavedra
ASOCIACION CIVIL SELVA AMAZONICA
Outcome results
None listed